Back

The KCNN3 rs13376333 risk variant reduces the SK-current density in isogenic stem cell-derived and native human atrial myocytes

29 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Advances in mechanisms, genetic insights, and therapeutic strategies for atrial fibrillation and atrial remodelling Arrhythmias ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Veronica Jimenez Sabado

IIB Sant Pau-CIBERCV, Barcelona (Spain)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor P. Hegner (Regensburg, DE)
Abstract
Presentation thumbnail
Professor Y. Etzion (Beer Sheva, IL)
Abstract Slides Video
Presentation thumbnail
Doctor M. Mattingsdal (Gjettum, NO)
Abstract
Presentation thumbnail
Mrs N. Suffee (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Advances in mechanisms, genetic insights, and therapeutic strategies for atrial fibrillation and atrial remodelling

The Event

Event poster

ESC Congress 2025

29 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Genetic aspects associated with increased risk of developing atrial fibrillation
thumbnail
Congress Presentation
Automated patch-clamp of human induced pluripotent stem cell (hiPSC) derived atrial cardiomyocytes as a promising technique to determine the electrophysiological impact of genetic risk variants
thumbnail
Congress Presentation
Unravelling the signaling pathway downstream of the neurokinin receptor in atrium: discovering novel anti-arrhythmic targets for treatment of atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources